Meet the Investors: Kairos Ventures
to
COVID-19 Testing Research
To add your information, please fill out this form.
Please look here for a list of potential COVID-19 Collaborators by Area of Expertise.
Nathaniel Bottman
RAPID: Optimizing group testing for SARS-CoV-2
Jason Doctor
Neeraj Sood
Michael Hochman
SARS-Cov-2 Antibody Testing in Vulnerable Communities
Kimon Drakopoulos
Ramandeep Randhawa
Studying the trade-off between increasing testing accuracy vs improving testing availability. See a 2-min video of research.
Michael Dube
Pooled and conventional nucleic acid testing strategies for SARS-CoV-2 to screen direct care research staff
Andrea Kovacs
Olivier Pernet
Toni Frederick
Eva Operskalski
Allison Bearden
Developing antibody testing from self-collected saliva, oral swabs blood, urine and GI samples. Also supporting clinical trials of emerging therapeutics by providing virologic testing.
Peter Kuhn
Developing novel application of the highly portable Nanopore Minion cartridge-based sequencing system for remote diagnostic COVID-19 testing.
Peter Kuhn
Cyrus Shahabi
Development and implementation of a novel mobile application to assess COVID-19 symptoms and facilitate geospatial activity mapping for managing disease surveillance and containment
Adam Smith
RAPID: Monitoring for SARS-CoV-2 in municipal wastewater and sewage to elucidate infection dynamics across major metropolitan areas of the United States
Brad Spellberg
Working on COVID testing in the population.
Bino Varghese
Artificial intelligence based chest x-ray instant triage product to identify COVID 19, community acquired pneumonias in community and hospital settings